In conformance with the Bursa Malaysia Listing Requirements, the following additional information is provided:
1. UTILISATION OF SUKUK PROGRAMME
During the year, Point Zone (M) Sdn Bhd has raised RM1,500.0 million to be utilised for refinancing outstanding amount of
previous Islamic Commercial Papers/Islamic Medium Term Notes Programme of up to RM500.0 million and to finance the
expansion and working capital requirements of the KPJ Groups’ healthcare and healthcare related businesses.
Amount up to (RM Million)
At 1 April 2015
1,500.0
Issued during the financial year
800.0
At 31 December 2015
700.0
2. TREASURY SHARES
In the previous financial year, the Company repurchased 15,520,000 of its issued share capital from the open market on
Bursa Malaysia Securities Berhad (“Bursa Malaysia”) at an average price of RM3.46 per share. The total consideration paid
for the repurchase including transaction costs was RM54,413,249. The shares repurchased are being held as treasury shares
in accordance with Section 67A of the Companies Act, 1965.
3. OPTIONS, WARRANTS OR CONVERTIBLE SECURITIES
On 29 January 2014, Warrants 2014/2019 were issued for free to the subscribers of the renounceable rights issue of
43,637,326 new ordinary shares of RM0.50 each in the Company’s Rights Shares on the basis of one (1) Rights Share for
every fifteen (15) existing shares held by the entitled shareholders of the Company, together with 87,274,652 free
detachable new warrants (“Warrants 2014/2019”) on the basis of two (2) Warrants 2014/2019 for every one (1) Rights
Share subscribed at an issue price of RM4.01 per Rights Share (“Rights Issue”).
Each new warrant (2014/2019) is entitled at any time during the exercise period, to subscribe for one (1) new ordinary
share at the exercise price of RM4.01.
4. AMERICAN DEPOSITORY RECEIPT (ADR) OR GLOBAL DEPOSITORY RECEIPT (GDR)
PROGRAMME
During the financial year, the Company did not issue any ADR or GDR Programme.
5. IMPOSITIONS OF SANCTIONS/PENALTIES
There were no sanctions and/or penalties imposed on the Company and its subsidiaries, Directors or Management by the
relevant regulatory bodies.
210
COMPLIANCE
INFORMATION
